127 related articles for article (PubMed ID: 11466867)
1. [A vaccination would prevent invasive pneumococcal infections in adults].
Herva E; Sankilampi U; Leinonen M
Duodecim; 1997; 113(8):689-91. PubMed ID: 11466867
[No Abstract] [Full Text] [Related]
2. Missed opportunities in vaccination of patients with subsequent pneumococcal bacteraemia.
Weightman NC; Walters A
Br J Gen Pract; 2003 Jul; 53(492):547-9. PubMed ID: 14694668
[TBL] [Abstract][Full Text] [Related]
3. Preventing pneumococcal disease.
Dobkin JF
AIDS Read; 2006 Feb; 16(2):81-2. PubMed ID: 16471273
[No Abstract] [Full Text] [Related]
4. Invasive pneumococcal infection in first nations children in northern Alberta.
Vaudry W; Talling D
Can Commun Dis Rep; 2002 Oct; 28(20):165-72. PubMed ID: 12402519
[No Abstract] [Full Text] [Related]
5. Pneumococcal vaccination in older adults.
Hirschmann JV
N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12917315
[No Abstract] [Full Text] [Related]
6. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination in older adults.
Fedson DS
N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924341
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
Bergman A; Hjelmgren J; Ortqvist A; Wisløff T; Kristiansen IS; Högberg LD; Persson KM; Persson U
Scand J Infect Dis; 2008; 40(9):721-9. PubMed ID: 18712627
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccination in older adults.
Marras TK
N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
[No Abstract] [Full Text] [Related]
10. Pneumococcal bacteraemia and opportunities for prevention.
Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
[TBL] [Abstract][Full Text] [Related]
11. [Influenza and pneumococcal vaccination in adults].
Weinke T; Güthoff W
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S82-5. PubMed ID: 19353477
[TBL] [Abstract][Full Text] [Related]
12. [Pneumococcal infections. Every second fatality within 48 hours].
MMW Fortschr Med; 2001 Nov; 143(47):60. PubMed ID: 11791369
[No Abstract] [Full Text] [Related]
13. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
[No Abstract] [Full Text] [Related]
14. Pneumococcal vaccination for Indian children.
Levine OS; Cherian T
Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
[No Abstract] [Full Text] [Related]
15. [Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis].
Postma MJ; Heijnen ML; Beutels P; Jager JC
Ned Tijdschr Geneeskd; 2002 May; 146(18):855-9. PubMed ID: 12038224
[TBL] [Abstract][Full Text] [Related]
16. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
17. [Pneumococcal vaccination for persons 65 years of age and older].
van den Bosch WJ
Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
[TBL] [Abstract][Full Text] [Related]
18. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
[TBL] [Abstract][Full Text] [Related]
19. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
Postma MJ; Heijnen ML; Beutels P; Jager JC
Expert Rev Vaccines; 2003 Aug; 2(4):477-82. PubMed ID: 14711333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
